Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05192889
Title Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
Recruitment Not yet recruiting
Gender
Phase Phase Ib/II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphoblastic leukemia

Therapies

Dexamethasone + Pegaspargase + Vincristine Sulfate

Blinatumomab + Cytarabine + Dexamethasone + Hydrocortisone + Methotrexate + Venetoclax

Cyclophosphamide + Cytarabine + Dexamethasone + Etoposide + Hydrocortisone + Leucovorin + Mercaptopurine + Methotrexate + Vincristine Sulfate

Cytarabine + Dexamethasone + Hydrocortisone + Mercaptopurine + Methotrexate + Vincristine Sulfate

Cytarabine + Dasatinib + Dexamethasone + Hydrocortisone + Methotrexate + Navitoclax + Pegaspargase + Venetoclax

Dasatinib + Dexamethasone + Pegaspargase + Vincristine Sulfate

Cytarabine + Dasatinib + Dexamethasone + Hydrocortisone + Mercaptopurine + Methotrexate + Vincristine Sulfate

Cytarabine + Dexamethasone + Hydrocortisone + Leucovorin + Methotrexate + Navitoclax + Pegaspargase + Venetoclax + Vincristine Sulfate

Cyclophosphamide + Cytarabine + Dasatinib + Dexamethasone + Etoposide + Hydrocortisone + Leucovorin + Mercaptopurine + Methotrexate + Vincristine Sulfate

Cytarabine + Dexamethasone + Hydrocortisone + Methotrexate + Navitoclax + Pegaspargase + Venetoclax

Cytarabine + Hydrocortisone + Leucovorin + Mercaptopurine + Methotrexate

Cytarabine + Dasatinib + Dexamethasone + Hydrocortisone + Leucovorin + Methotrexate + Navitoclax + Pegaspargase + Venetoclax + Vincristine Sulfate

Blinatumomab + Cytarabine + Dasatinib + Dexamethasone + Hydrocortisone + Methotrexate + Venetoclax

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.